Skip to content

EXOZ EXOZ Debt-to-assets

Debt-to-assets at other companies

Gevo logo
GevoGEVO
0.0×
Ginkgo Bioworks logo
Ginkgo BioworksDNA
0.4×+0.1×
NAG
Niagen Bioscience, Inc. Common StockNAGE
0.0×
Nature's Sunshine Products logo
Nature's Sunshine ProductsNATR
0.1×0.0×
Opko Health logo
Opko HealthOPK
0.0×
Upexi logo
UpexiUPXI
1.2×+1.1×

Other financials

Income statement

See full
Revenue$17.5K
Operating income-$2.4M-22.4%
Net income-$2.4M-27.7%
EPS (diluted)-$0.28-27.3%

Balance sheet

See full
Cash & equivalents$1.4M-83.0%
Total debt$1.2M-8.8%
Total equity$1.5M-82.8%
Total assets$4.0M-65.1%

Cash flow

See full
Operating cash flow-$1.5M-34.5%
CapEx$57.6K+85.5%
Free cash flow-$1.6M-35.8%

Valuation

See full
Market cap$76.8M-3.3%
Enterprise value$76.57M+3.5%
P/S1,096.1×

Profitability

See full
Operating margin-14,489.6%
Net margin-2,909.1%
FCF margin-10,117.8%

Returns & leverage

See full
Return on equity-185.8%
Debt / equity0.8×+0.6×
Current ratio1.3×-5.2×

Where this comes from

Calculated from EXOZ’s reported figures.

Based on the most recent quarter.

The official record: EXOZ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about EXOZ's debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is EXOZ's debt-to-assets?
EXOZ (EXOZ) reported debt-to-assets of 0.3× in Q1 2026.
How has EXOZ's debt-to-assets changed year-over-year?
EXOZ's debt-to-assets increased by 161.6% year-over-year, from 0.1× to 0.3×.
What is the long-term trend for EXOZ's debt-to-assets?
Over 2 years (2023 to 2025), EXOZ's debt-to-assets has grown at a -31.0% compound annual growth rate (CAGR), from 0.5× to 0.2×.
What does debt-to-assets mean?
Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.